Erudio Healtherudio.com
Drug
Afatinib trials: what clinicians said in public
No HCP commentary report on a trial studying afatinib yet. Erudio has found public clinician commentary on 2 clinical trials studying afatinib: CodeBreaK 101 and KRYSTAL-1. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| KRYSTAL-1 NCT03785249 · Mirati Therapeutics Inc. DeepView → | KRAS G12C-mutated advanced solid tumors | Phase 1/Phase 2 | Deep | View | |||
| CodeBreaK 101 NCT04185883 · Amgen DeepView → | KRAS G12C-mutated advanced solid tumors | Phase 1 | Deep | View | |||